Unique ID issued by UMIN | UMIN000002836 |
---|---|
Receipt number | R000003460 |
Scientific Title | Development of new positioning system in stereotactic irradiation for the brain tumor by linac-mounted cone-beam CT with contrast media administration |
Date of disclosure of the study information | 2009/12/04 |
Last modified on | 2010/12/03 14:10:34 |
Development of new positioning system in stereotactic irradiation for the brain tumor by linac-mounted cone-beam CT with contrast media administration
Development of new positioning system in stereotactic irradiation for the brain tumor by linac-mounted cone-beam CT with contrast media administration
Development of new positioning system in stereotactic irradiation for the brain tumor by linac-mounted cone-beam CT with contrast media administration
Development of new positioning system in stereotactic irradiation for the brain tumor by linac-mounted cone-beam CT with contrast media administration
Japan |
metastatic brain tumor
Radiology |
Malignancy
NO
To develop the new non-invasive positioning system in stereotactic irradiation for brain tumor by linac-mounted cone-beam CT with contrast media administration
Safety,Efficacy
Setup error at the positioning
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine | Device,equipment |
The patient is setup by registration of kilovoltage cone-beam CT under contrast media administration to the planning CT.
20 | years-old | <= |
Not applicable |
Male and Female
Metastatic brain tumors with maximum size of < 3 cm and less than 3 lesions
Histopathological confirmation of malignancy in the primary site
No history of intracranial irradiation
Tumors enhanced by contrast media administration
Laboratory tests within 28 days before accrual
1. WBC >= 4,000/mm3 and < 12,000/mm3
2. Neutrophil >= 2,000/mm3
3. Platelet >= 50,000/mm3
4. Hb >= 8.0 g/dl
5. Cre <= 1.1 mg/dl
6. expected Ccr >= 50ml/min (Cockcroft-Gault)
PS 0-2, or PS3 due to the neurologic symptoms by brain tumor
Age >= 20
Written informed consent
Active multiple cancer
Women with pregnancy or with intent or possibility of pregnancy
Chemotherapeutic agent (excluding hormone therapy) administered within 14 days
Chronic renal failure requiring medical intervention
Difficulty in application of head fixation shell
History of an allergic reaction to iodine contrast media
History of asthma
Other conditions inappropriate for accrual
10
1st name | |
Middle name | |
Last name | Hiroshi Igaki |
Teikyo University School of Medicine
Department of Radiology
2-11-1, Kaga, Itabashi-ku, Tokyo
03-3964-1211
1st name | |
Middle name | |
Last name | Hiroshi Igaki |
Teikyo University Hospital
Department of Radiology
2-11-1, Kaga, Itabashi-ku, Tokyo
03-3964-1211
Teikyo University School of Medicine
Teikyo University School of Medicine
Self funding
NO
帝京大学医学部附属病院(東京都)
2009 | Year | 12 | Month | 04 | Day |
Unpublished
Terminated
2009 | Year | 06 | Month | 15 | Day |
2009 | Year | 11 | Month | 01 | Day |
2012 | Year | 03 | Month | 01 | Day |
2009 | Year | 12 | Month | 03 | Day |
2010 | Year | 12 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003460